the effect of tranexamic acid dissolved in hot ,cold and room temperature washing fluid on complications of TURP surgery

A comparative study of the effect of tranexamic acid dissolved in hot ,cold and room temperature washing fluid on reducing bleeding during surgery and postoperative complications in TURP surgery

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20230521058247N1

Enrollment

Registered

2023-10-16

Start date

2023-05-15

Completion date

Unknown

Last updated

2023-11-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Benign hyperplasia of prostate. Enlarged prostate

Interventions

Intervention 1: Control group: Use of routine washing solution during operation. Intervention 2: Intervention1 group: Use of warm washing solution (37°C) in combination with tranexamic acid. Intervent

Eligibility

Sex/Gender

Male

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: Age over 18 years prostate weight less than 70 grams no coagulation disorders no history of cardiovascular diseases no history of prostate cancer hemoglobin greater than or equal to 10 no history of atrial fibrillation and coronary artery disease thrombophilia severe form of chronic renal failure allergy to tranexamic acid

Exclusion criteria

Exclusion criteria: The presence of sensitivity to tranexamic acid drug the duration of surgery is more than 3 hours the need for anesthesia other than spinal anesthesia

Design outcomes

Primary

Measure	Time frame
Bleeding. Timepoint: From the start of the operation to the end of the operation. Method of measurement: Homeco photometer.;Shivering. Timepoint: Immediately after the operation. Method of measurement: Mahajan and Grossely shivering scale.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr. Behzad Imani

Hamedan University of Medical Sciences

Behzadiman@yahoo.com0098918811436

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026